SMPDL3B mRNA expression level (HR = 1.927, p = 0.0079), together with age, cytogenetics risk, and IDH1, was a significant independent prognostic factor for overall survival of AML patients. The gene discussed is IDH1; the disease is acute myeloid leukemia.